US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

BioLife Solutions, Inc.

us-stock
To Invest in {{usstockname}}
us-stock
$25.48 0.0055(0.55%) BLFS at 04 Dec 2025 04:27 PM Medical Instruments & Supplies
Lowest Today 25.45
Highest Today 25.75
Today’s Open 25.49
Prev. Close 25.37
52 Week High 29.62
52 Week Low 19.10
Day’s Range: Low 25.45 High 25.75
52-Week Range: Low 19.10 High 29.62
1 day return -
1 Week return -4.07
1 month return -5.76
3 month return -1.27
6 month return +15.89
1 year return -3.44
3 year return +34.95
5 year return -34.41
10 year return -

Institutional Holdings

Casdin Capital, LLC 16.11

BlackRock Inc 11.58

T. Rowe Price Investment Management,Inc. 8.88

Amvescap Plc. 7.49

Vanguard Group Inc 6.06

iShares Core S&P Small-Cap ETF 4.61

T. Rowe Price US Small-Cap Core Equity 3.98

T. Rowe Price Small-Cap Stock 3.90

State Street Corp 2.95

Vanguard Total Stock Mkt Idx Inv 2.89

Fred Alger Management, LLC 2.61

Alger Small Cap Focus Composite 2.46

Alger Small Cap Focus I 2.46

Massachusetts Financial Services Company 2.30

Rockefeller Capital Management L.P. 2.30

Ameriprise Financial Inc 2.26

Dimensional Fund Advisors, Inc. 2.06

T. Rowe Price Instl Small-Cap Stock 1.97

T. Rowe Price U.S. SC Core Eq Tr-D 1.96

iShares Russell 2000 ETF 1.93

Geode Capital Management, LLC 1.93

Palisade Capital Management LLc 1.92

Geneva Capital Management 1.89

Columbia Acorn Inst 1.75

Royal Bank of Canada 1.65

ING Investment Management LLC 1.51

MFS New Discovery I 1.50

Cramer Rosenthal McGlynn LLC 1.47

Bank of America Corp 1.40

Invesco Main Street Small Cap R6 1.40

Invesco Small Cap Core 1.38

Invesco Small Cap Growth A 1.37

Granahan Investment Management Inc.. 1.34

Mutual Of America Capital Management LLC 1.33

JNL/Invesco Small Cap Growth A 1.25

Stephens Small Cap Growth 1.11

Palisade Small Cap Core Equity 1.10

Voya Small Cap Growth 0.88

Voya Small Cap Growth I 0.88

Vanguard Institutional Extnd Mkt Idx Tr 0.83

Market Status

Strong Buy: 7

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 1221.52 M

PB Ratio 3.4545

PE Ratio 0.0

Enterprise Value 1163.72 M

Total Assets 399.49 M

Volume 157455

Company Financials

Annual Revenue FY23:154797000 154.8M, FY22:161759000 161.8M, FY21:119156000 119.2M, FY20:48087000 48.1M, FY19:27371000 27.4M

Annual Profit FY23:51473000 51.5M, FY22:53822000 53.8M, FY21:37748000 37.7M, FY20:27441000 27.4M, FY19:18513000 18.5M

Annual Net worth FY23:-102234000 -102.2M, FY22:-139805000 -139.8M, FY21:-8383000 -8.4M, FY20:2667000 2.7M, FY19:11062000 11.1M

Quarterly Revenue Q3/2025:28067000 28.1M, Q2/2025:25421000 25.4M, Q1/2025:23941000 23.9M, Q3/2024:30571000 30.6M, Q2/2024:28328000 28.3M

Quarterly Profit Q3/2025:18779000 18.8M, Q2/2025:16433000 16.4M, Q1/2025:15786000 15.8M, Q3/2024:21806000 21.8M, Q2/2024:14893000 14.9M

Quarterly Net worth Q3/2025:621000 0.6M, Q2/2025:-15838000 -15.8M, Q1/2025:-448000 -0.4M, Q3/2024:-1703000 -1.7M, Q2/2024:-20719000 -20.7M

Fund house & investment objective

Company Information BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Organisation Medical Instruments & Supplies

Employees 159

Industry Medical Instruments & Supplies

CEO Mr. Roderick de Greef

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right